NGL Fine-Chem Ltd.
NSE: NGLFINE | BSE: 524774
₹2,410.00
₹-0.10 (0.00%)As on 21-May-2026 09:04IST
Market cap
₹1,492 Cr
Revenue (TTM)
₹447 Cr
P/E Ratio
42.5
P/B Ratio
4.7
Div. Yield
0.1 %
Quality Score
5/10
Growth Score
7/10
Valuation Score
3/10
Momentum Score
10/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹35 Cr
-
ROE
7.8 %
-
ROCE
9.4 %
-
Industry P/E
41.34
-
EV/EBITDA
22.9
-
Debt to Equity
0.3
-
Book Value
₹511.3
-
EPS
₹56.8
-
Face value
5
-
Shares outstanding
6,178,024
10 Years Aggregate
CFO
₹202.78 Cr
EBITDA
₹392.84 Cr
Net Profit
₹256.93 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
NGL Fine-Chem
| 71.4 | 4.8 | 2.7 | 83.7 | 16.6 | -- | -- |
|
BSE Healthcare
| 10.6 | 10.7 | 11.4 | 13.8 | 28.2 | 14.5 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
NGL Fine-Chem
| -22.0 | -16.2 | 45.2 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
NGL Fine-Chem
|
2,410.0 | 1,492.1 | 446.9 | 35.1 | 8.7 | 12 | 42.5 | 4.7 |
| 2,897.1 | 23,623.9 | 1,339.4 | 356.4 | 33.2 | 23.2 | 66.3 | 14.3 | |
| 3,184.0 | 39,860.7 | 5,452.9 | 1,056.0 | 22.4 | 23.9 | 37.7 | 8.8 | |
| 1,737.0 | 32,846.4 | 9,203.5 | 941.3 | 15.4 | 19.6 | 35.5 | 6.6 | |
| 1,840.0 | 1,565.1 | 332.6 | 51.1 | 20.4 | 15.4 | 28.1 | 4.3 | |
| 2,166.0 | 34,686.3 | 4,147.8 | 709.5 | 22.3 | 18.3 | 48.9 | 8.3 | |
| 4,680.0 | 21,436.9 | 2,519.7 | 722.4 | 33.6 | 18.8 | 29.7 | 5.1 | |
| 176.2 | 23,447.9 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.9 | |
| 252.0 | 11,013.6 | 2,643.8 | 152.1 | 12.0 | 7.7 | 62.1 | 3.8 | |
| 1,613.0 | 26,182.4 | 3,373.0 | 199.0 | 12.6 | 5.9 | 122.9 | 5.3 |
Shareholding Pattern
View DetailsNews & Analysis
All News
About NGL Fine-Chem
NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for usage in veterinary and human health in India, Europe, the Asia Pacific, the United States, and internationally. The company offers animal health pharmaceutical... ingredients, such as homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosphan, imidocarb dipropionate, triclabendazole, rafoxanide, diminazene aceturate, s-methoprene, carprofen, diminazene diaceturate, ractopamine HCI, toltrazuril, decoquinate, amitraz, marbofloxacin, flunixin meglumine, praziquantel, fenbendazole, and xylazine hydrochloride. It also provides human health pharmaceutical ingredients, including nitazoxanide and atovaquone; and intermediates and specialty chemicals comprising 1,4,7-Trimethyl-1,4,7-Triazacylononane and N-ethyl glucamine. In addition, the company offers finished dosage forms, including diminazene aceturate granules and homidium chloride tablets. NGL Fine-Chem Limited was incorporated in 1981 and is based in Mumbai, India. Read more
-
Incorporated
1981
-
Chairman
Dhananjay Mungale
-
Managing Director
Rahul Nachane
-
Headquarters
Mumbai, Maharashtra
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsNo News & Announcements are available.
FAQs for NGL Fine-Chem
What is the current share price of NGL Fine-Chem Ltd Today?
The share price of NGL Fine-Chem Ltd is ₹2,410.00 (NSE) and ₹2,415.15 (BSE) as of 21-May-2026 09:04 IST. NGL Fine-Chem Ltd has given a return of 16.6% in the last 3 years.
What is the current PB & PE ratio of NGL Fine-Chem Ltd?
The P/E ratio of NGL Fine-Chem Ltd is 42.51 times as on 20-May-2026, a 3 premium to its peers’ median range of 41.34 times.
The P/B ratio of NGL Fine-Chem Ltd is 4.72 times as on 20-May-2026, a 15 discount to its peers’ median range of 5.56 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
32.97
|
2.44
|
|
2024
|
31.37
|
4.92
|
|
2023
|
36.22
|
3.32
|
|
2022
|
24.27
|
5.95
|
|
2021
|
16.74
|
6.13
|
What is the 52 Week High and Low of NGL Fine-Chem Ltd?
The 52-week high and low of NGL Fine-Chem Ltd are Rs 2,767.90 and Rs 0.00 as of 21-May-2026.
What is the market cap of NGL Fine-Chem Ltd?
NGL Fine-Chem Ltd has a market capitalisation of ₹ 1,492 Cr as on 20-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in NGL Fine-Chem Ltd?
Before investing in NGL Fine-Chem Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.